Papadimitriou-Olivgeris Matthaios, Battistolo Julien, Poissy Julien, Coste Alix, Bochud Pierre-Yves, Calandra Thierry, Senn Laurence, Lamoth Frédéric
Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Institute of Microbiology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
Open Forum Infect Dis. 2022 Jul 30;9(8):ofac383. doi: 10.1093/ofid/ofac383. eCollection 2022 Aug.
Despite advances in diagnostic and therapeutic approaches, candidemia remains associated with high mortality rates. This study aimed at identifying predictors of mortality among patients with candidemia, with a focus on early interventions that can improve prognosis.
This was a single-center retrospective study including all adult patients with at least 1 positive blood culture for species from 2014 to 2021.
A total of 222 episodes of candidemia were included. Most candidemias were of unknown origin (36%) or vascular catheter related (29%). Septic shock developed in 29% episodes. Overall, 14-day mortality rate was 23%. In univariate analyses, septic shock was associated with higher 14-day mortality, whereas catheter-related candidemia and early (<72 hours) interventions, such as appropriate antifungal therapy, source control, and infectious diseases consultation, were associated with improved survival. In a Cox multivariate regression model, septic shock (odds ratio [OR], 3.62 [95% confidence interval {CI}, 2.05-6.38]) was associated with higher mortality. While the impact of early antifungal therapy did not reach statistical significance, early (<72 hours) infectious diseases consultation (OR, 0.46 [95% CI, .23-.91]) and early source control (OR, 0.15 [95% CI, .08-.31]) were associated with better survival. Subanalyses showed that the benefits of early source control, specifically catheter removal, were significant among patients with sepsis or septic shock, but not among those without sepsis. These associations remained significant after exclusion of patients who died prematurely or were in palliative care.
Early source control, in particular catheter removal, was a key determinant of outcome among candidemic patients with sepsis or septic shock.
尽管诊断和治疗方法取得了进展,但念珠菌血症的死亡率仍然很高。本研究旨在确定念珠菌血症患者的死亡预测因素,重点关注可改善预后的早期干预措施。
这是一项单中心回顾性研究,纳入了2014年至2021年期间所有血培养至少有1次念珠菌属阳性的成年患者。
共纳入222例念珠菌血症病例。大多数念珠菌血症来源不明(36%)或与血管导管相关(29%)。29%的病例发生了感染性休克。总体而言,14天死亡率为23%。在单因素分析中,感染性休克与14天死亡率较高相关,而导管相关念珠菌血症和早期(<72小时)干预措施,如适当的抗真菌治疗、源头控制和感染病会诊,与生存率提高相关。在Cox多变量回归模型中,感染性休克(比值比[OR],3.62[95%置信区间{CI},2.05 - 6.38])与较高的死亡率相关。虽然早期抗真菌治疗的影响未达到统计学意义,但早期(<72小时)感染病会诊(OR,0.46[95%CI,0.23 - 0.91])和早期源头控制(OR,0.15[95%CI,0.08 - 0.31])与更好的生存率相关。亚组分析表明,早期源头控制,特别是拔除导管,在脓毒症或感染性休克患者中益处显著,但在无脓毒症患者中则不然。排除过早死亡或接受姑息治疗的患者后,这些关联仍然显著。
早期源头控制,特别是拔除导管,是患有脓毒症或感染性休克的念珠菌血症患者预后的关键决定因素。